PBGENE-ALS

N/A

Report date: 2025/11/24 11:12:19

Base Information

Drug NamePBGENE-ALS
Drug Alias NamePBGENE-ALS
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionGuanine nucleotide exchange C9orf72 modulators
TargetsGuanine nucleotide exchange C9orf72
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecision Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A